Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Hillcrest Clinical Research, LLC
mi
from
Simpsonville, SC
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Hillcrest Clinical Research, LLC
mi
from
Simpsonville, SC
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Midwest Medical Care
mi
from
Sioux Falls, SD
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Midwest Medical Care
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Gastroenterology Associates
mi
from
Bristol, TN
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Gastroenterology Associates
mi
from
Bristol, TN
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
ClinSearch, LLC
mi
from
Chattanooga, TN
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
ClinSearch, LLC
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Alpha Clinical Research
mi
from
Clarksville, TN
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Alpha Clinical Research
mi
from
Clarksville, TN
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Memphis Gastroenterology Group
mi
from
Germantown, TN
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Memphis Gastroenterology Group
mi
from
Germantown, TN
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Associates in Gastroenterology
mi
from
Hermitage, TN
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Associates in Gastroenterology
mi
from
Hermitage, TN
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Gastroenterology Associates Clinical Research
mi
from
Kingsport, TN
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Gastroenterology Associates Clinical Research
mi
from
Kingsport, TN
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Dial Research Associates, INC
mi
from
Nashville, TN
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Dial Research Associates, INC
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Columbia Medical Group -The First Clinic, Inc.
mi
from
Nashville, TN
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Columbia Medical Group -The First Clinic, Inc.
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
TN Medical Research
mi
from
Spring Hill, TN
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
TN Medical Research
mi
from
Spring Hill, TN
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Research Across America/ Family Medicine Associates of Texas
mi
from
Carrollton, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Research Across America/ Family Medicine Associates of Texas
mi
from
Carrollton, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Corsicana Medical Research
mi
from
Corsicana, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Corsicana Medical Research
mi
from
Corsicana, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Texas University Health Sciences Center
mi
from
El Paso, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Texas University Health Sciences Center
mi
from
El Paso, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Pioneer Research Solutions
mi
from
Sugar Land, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Pioneer Research Solutions
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Houston S. Endoscopy and Research Center
mi
from
Houston, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Houston S. Endoscopy and Research Center
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Digestive Associates of Houston
mi
from
Houston, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Digestive Associates of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Gastroenterology Consultants
mi
from
Houston, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Gastroenterology Consultants
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Spring Gastroenterology Associates
mi
from
Humble, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Spring Gastroenterology Associates
mi
from
Humble, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Digestive Health Associates of Texas
mi
from
Plano, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Digestive Health Associates of Texas
mi
from
Plano, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Sun Research Institute
mi
from
San Antonio, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Sun Research Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Panacea Clinical Research
mi
from
San Antonio, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Panacea Clinical Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Pioneer Research Solutions, Inc.
mi
from
Houston, TX
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Pioneer Research Solutions, Inc.
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Advanced Research Institute
mi
from
Ogden, UT
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Advanced Research Institute
mi
from
Ogden, UT
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Charlottesville Medical Reserch
mi
from
Charlottesville, VA
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Charlottesville Medical Reserch
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Gastroenterology Associates of Tidewater
mi
from
Chesapeake, VA
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Gastroenterology Associates of Tidewater
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Gastroenterology, Ltd.
mi
from
Virginia Beach, VA
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Gastroenterology, Ltd.
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Wisconsin Center for Advanced Research
mi
from
Milwaukee, WI
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Wisconsin Center for Advanced Research
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Aurora Advanced Healthcare, Inc-Clinical Research Center
mi
from
Milwaukee, WI
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Aurora Advanced Healthcare, Inc-Clinical Research Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Discovery Research
mi
from
West Bend, WI
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Discovery Research
mi
from
West Bend, WI
Click here to add this to my saved trials
Effect of Tolvaptan on Cognitive Function in Cirrhosis
Effects of Tolvaptan on Cognitive Function, Brain Metabolism and Quality of Life in Hyponatremic Cirrhotics With Hepatic Encephalopathy: A Prospective Clinical Trial
Status: Enrolling
Updated:  12/10/2012
Hunter Holmes McGuire VA Medical Center
mi
from
Richmond, VA
Effect of Tolvaptan on Cognitive Function in Cirrhosis
Effects of Tolvaptan on Cognitive Function, Brain Metabolism and Quality of Life in Hyponatremic Cirrhotics With Hepatic Encephalopathy: A Prospective Clinical Trial
Status: Enrolling
Updated: 12/10/2012
Hunter Holmes McGuire VA Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents
A Randomized Controlled Trial Comparing Buprenorphine/Naloxone With Naltrexone for Treatment in Opioid Dependent Adolescents and Young Adults
Status: Enrolling
Updated:  12/11/2012
Sheehan Memorial Hospital
mi
from
Buffalo, NY
Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents
A Randomized Controlled Trial Comparing Buprenorphine/Naloxone With Naltrexone for Treatment in Opioid Dependent Adolescents and Young Adults
Status: Enrolling
Updated: 12/11/2012
Sheehan Memorial Hospital
mi
from
Buffalo, NY
Click here to add this to my saved trials
Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents
A Randomized Controlled Trial Comparing Buprenorphine/Naloxone With Naltrexone for Treatment in Opioid Dependent Adolescents and Young Adults
Status: Enrolling
Updated:  12/11/2012
UB Department of Family Medicine
mi
from
Buffalo, NY
Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents
A Randomized Controlled Trial Comparing Buprenorphine/Naloxone With Naltrexone for Treatment in Opioid Dependent Adolescents and Young Adults
Status: Enrolling
Updated: 12/11/2012
UB Department of Family Medicine
mi
from
Buffalo, NY
Click here to add this to my saved trials
Probiotics in Hospitalized Patients Study
Randomized Double-blind, Placebo-Controlled Trial Comparing the the Effect of Enhance Probiotic (EP, Go Live Rx,) Versus Placebo (Pl) on the Incidence of Clostridium Difficile Associated Diarrhea (CDAD) or Antibiotic-Associated Diarrhea (AAD)in Hospitalized Patients Initiated on Antibiotics
Status: Enrolling
Updated:  12/11/2012
South Shore Hospital
mi
from
Weymouth, MA
Probiotics in Hospitalized Patients Study
Randomized Double-blind, Placebo-Controlled Trial Comparing the the Effect of Enhance Probiotic (EP, Go Live Rx,) Versus Placebo (Pl) on the Incidence of Clostridium Difficile Associated Diarrhea (CDAD) or Antibiotic-Associated Diarrhea (AAD)in Hospitalized Patients Initiated on Antibiotics
Status: Enrolling
Updated: 12/11/2012
South Shore Hospital
mi
from
Weymouth, MA
Click here to add this to my saved trials
Plastic Bronchitis and Protein Losing Enteropathy in Children With Single Ventricle Physiology
An Investigation Into The Potential Roles Of Vasoactive Intestinal Peptide And Substance P In The Pathophysiology Of Plastic Bronchitis And Protein Losing Enteropathy In Children With Palliated Single Ventricle Physiology
Status: Enrolling
Updated:  12/11/2012
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Plastic Bronchitis and Protein Losing Enteropathy in Children With Single Ventricle Physiology
An Investigation Into The Potential Roles Of Vasoactive Intestinal Peptide And Substance P In The Pathophysiology Of Plastic Bronchitis And Protein Losing Enteropathy In Children With Palliated Single Ventricle Physiology
Status: Enrolling
Updated: 12/11/2012
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's Disease
Phase III Study to Evaluate the Effect of 10% Metronidazole Ointment, Applied Topically Three Times a Day in and Around the Anus and the Change in Perianal Crohn's Disease Activity
Status: Enrolling
Updated:  12/12/2012
Washington University School of Medicine
mi
from
St Louis, MO
Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's Disease
Phase III Study to Evaluate the Effect of 10% Metronidazole Ointment, Applied Topically Three Times a Day in and Around the Anus and the Change in Perianal Crohn's Disease Activity
Status: Enrolling
Updated: 12/12/2012
Washington University School of Medicine
mi
from
St Louis, MO
Click here to add this to my saved trials
Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's Disease
Phase III Study to Evaluate the Effect of 10% Metronidazole Ointment, Applied Topically Three Times a Day in and Around the Anus and the Change in Perianal Crohn's Disease Activity
Status: Enrolling
Updated:  12/12/2012
Derby City General Hospital
mi
from
Derby,
Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's Disease
Phase III Study to Evaluate the Effect of 10% Metronidazole Ointment, Applied Topically Three Times a Day in and Around the Anus and the Change in Perianal Crohn's Disease Activity
Status: Enrolling
Updated: 12/12/2012
Derby City General Hospital
mi
from
Derby,
Click here to add this to my saved trials
Prospective Evaluation of a New Covered Metal Stent for Malignant Lesions of the Esophagus
Prospective Evaluation of a New Covered Metal Stent for Malignant Lesions of the Esophagus
Status: Enrolling
Updated:  12/18/2012
Weill Medical College of Cornell University
mi
from
New York, NY
Prospective Evaluation of a New Covered Metal Stent for Malignant Lesions of the Esophagus
Prospective Evaluation of a New Covered Metal Stent for Malignant Lesions of the Esophagus
Status: Enrolling
Updated: 12/18/2012
Weill Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Effects of Vitamin D on Inflammation in Liver Disease
Effects of Vitamin D on Inflammation in Liver Disease
Status: Enrolling
Updated:  12/18/2012
UC San Diego, CTRI
mi
from
La Jolla, CA
Effects of Vitamin D on Inflammation in Liver Disease
Effects of Vitamin D on Inflammation in Liver Disease
Status: Enrolling
Updated: 12/18/2012
UC San Diego, CTRI
mi
from
La Jolla, CA
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
University of Arizona
mi
from
Tucson, AZ
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
University of California at Los Angeles
mi
from
Los Angeles, CA
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
Leland Stanford Junior University
mi
from
Palo Alto, CA
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Leland Stanford Junior University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
Piedmont Hospital, Incorporated
mi
from
Atlanta, GA
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Piedmont Hospital, Incorporated
mi
from
Atlanta, GA
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
Northwestern University
mi
from
Chicago, IL
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
Rush University Medical Center
mi
from
Chicago, IL
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
Indiana University
mi
from
Indianapolis, IN
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
University of Kansas Medical Center Research Institute, Inc.
mi
from
Kansas City, KA
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
University of Kansas Medical Center Research Institute, Inc.
mi
from
Kansas City, KA
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
University of Maryland, Baltimore
mi
from
Baltimore, MD
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
University of Maryland, Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
University of Michigan
mi
from
Ann Arbor, MI
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials